Recent Finacing
Recent Raise
iVeena is a clinical-stage ophthalmology biopharma developing non-surgical ophthalmic drops—IVMED-80 for keratoconus and LOX-activating IVMED-85/95 for pediatric and adult myopia, advancing toward IND/Phase 2.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at iVeena.
